A fundamental shift in the treatment of acute decompensated heart failure
ADHF is an episode of worsening heart failure symptoms in which patients experience difficulty breathing, fatigue, and swelling due to fluid back-up in the lungs and other parts of the body. Efficient and complete removal of excess fluid from the body’s tissues is vital to improve patient outcomes. WhiteSwell’s therapy is designed to leverage the impressive drainage capabilities of the lymphatic system to shift fluids out of the interstitial compartment, the fluid-filled spaces in connective tissue throughout the body, and into the vascular compartment (blood vessels). From there, excess fluid is removed through diuresis.
Leveraging the Lymphatic System to Treat ADHF
WhiteSwell is a science-driven company dedicated to improving treatment of acute decompensated heart failure (ADHF), a primary cause of repeat hospitalization and emergency room visits. The quest to address this big clinical need brought Yaacov Nitzan and team to explore the therapeutic potential of the lymphatic system, establishing WhiteSwell in 2014. WhiteSwell’s solution is uniquely designed to facilitate removal of fluid from both the interstitial and intravascular compartments.